4.1 Article

Exposure-Response Analysis of Vamorolone (VBP15) in Boys With Duchenne Muscular Dystrophy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Latent process model of the 6-minute walk test in Duchenne muscular dystrophy A Bayesian approach to quantifying rare disease progression

Janelle L. Lennie et al.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2020)

Article Pharmacology & Pharmacy

Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy

Panteleimon D. Mavroudis et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Article Pharmacology & Pharmacy

Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy

Daniela J. Conrado et al.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2019)

Article Multidisciplinary Sciences

Cryptic glucocorticoid receptor-binding sites pervade genomic NF-κB response elements

William H. Hudson et al.

NATURE COMMUNICATIONS (2018)

Article Biotechnology & Applied Microbiology

Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit

Sen Chandra Sreetama et al.

MOLECULAR THERAPY (2018)

Article Gastroenterology & Hepatology

Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease

Christopher R. Heier et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)

Review Pediatrics

Duchenne muscular dystrophy

Eppie M. Yiu et al.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2015)

Review Cell Biology

Immune-mediated pathology in Duchenne muscular dystrophy

Amy S. Rosenberg et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Pharmacology & Pharmacy

Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development

R. V. Overgaard et al.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)

Article Medicine, Research & Experimental

VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects

Christopher R. Heier et al.

EMBO MOLECULAR MEDICINE (2013)

Article Multidisciplinary Sciences

VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice

Jesse M. Damsker et al.

PLOS ONE (2013)

Article Clinical Neurology

THE 6-MINUTE WALK TEST IN DUCHENNE/BECKER MUSCULAR DYSTROPHY: LONGITUDINAL OBSERVATIONS

Craig M. McDonald et al.

MUSCLE & NERVE (2010)